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Abstract
Background: The aggregation of the baker’s yeast prion Sup35p is at the origin of the transmissible [PSI
+] trait. We and
others have shown that molecular chaperones modulate Sup35p aggregation. However, other protein classes might be
involved in [PSI
+] formation.
Results: We designed a functional proteomic study that combines two techniques to identify modulators of Sup35p
aggregation and describe the changes associated to [PSI
+] formation. The first allows measuring the effect of fractionated
Saccharomyces cerevisiae cytosolic extracts from [PSI
+] and [psi
2] yeast cells on Sup35p assembly. The second is a multiplex
qualitative and quantitative comparison of protein composition of active and inactive fractions using a gel-free and label-
free LC-MS approach. We identify changes in proteins involved in translation, folding, degradation, oxido-reduction and
metabolic processes.
Conclusion: Our functional proteomic study provides the first inventory list of over 300 proteins that directly or indirectly
affect Sup35p aggregation and [PSI
+] formation. Our results highlight the complexity of the cellular changes accompanying
[PSI
+] formation and pave the way for in vitro studies aimed to document the effect of individual and/or combinations of
proteins identified here, susceptible of affecting Sup35p assembly.
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Introduction
Infectious proteins (prions) aggregation is at the origin of
neurodegeneration in higher vertebrates [1]. Prions have indeed
the ability to undergo conformational conversion from a functional
constitutive form to non-functional and toxic, high molecular
weight species that recruit functional prions and convert them to
the non-functional forms [2]. Thus, prion aggregation is a self-
perpetuating process and the breakage of the aggregates into
smaller aggregates contributes to an amplification of the
aggregation process [3].
Prions are at the origin of dominant phenotypic traits that are
inherited in a non-Mendelian manner and are transmissible by
cytoduction in the yeast Saccharomyces cerevisiae [4]. Three such traits
are actively studied: [PSI
+], [URE3] and [PIN
+]. They are due to
the aggregation of the proteins Sup35, Ure2 and Rnq1,
respectively. These proteins readily assemble under physiological
salt conditions and neutral pH into fibrillar high molecular weight
particles [5–8]. Yeast prions N-terminal moieties that are essential
for prion aggregation and propagation are unusually rich in
glutamine and asparagine residues. They resemble in that to
huntingtin which aggregation is involved in the neurodegenerative
Huntington’s disease. Thus, yeast prions constitute good models to
document the mechanism of protein aggregation and conforma-
tional conversion propagation observed in conformational neuro-
logical diseases.
The eukaryotic release factor Sup35p, also known as eRF3,
mediates together with Sup45p (eRF1), ribosomal translation
termination [9]. In [PSI
+] cells, the aggregation of Sup35p alters
translation termination and leads to an increased tendency of the
ribosomes to read through nonsense ochre stop codons [10].
In vivo, the propagation of [PSI
+] is highly dependent on the
expression of molecular chaperones. We recently documented in
vitro the assembly of Sup35p alone and in the presence of
molecular chaperones from the Hsp40, Hsp70 and Hsp100
families alone or in concert, and showed that molecular
chaperones finely tune the aggregation of Sup35p [11]. Indeed,
while the yeast Hsp70 Ssa1p, together with its Hsp40 co-
chaperones Sis1p or Ydj1p was shown to sequester Sup35p, in
an ATP-dependent manner, in assembly incompetent oligomeric
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polymerization [11]. We also documented the functional interplay
between chaperones and demonstrated that Ssa1p together with
Sis1p or Ydj1p and ATP counteract the assembly stimulatory
effect of Hsp104p.
Classical proteomic, approaches including aggregates purifica-
tion and immune precipitation, 2D gel electrophoresis and mass
spectrometric identification of proteins, have been recently used to
document the changes in protein expression profiles accompany-
ing cell degeneration in a number of neurodegenerative diseases
[12–16], including prion disease [17]. More recently, mass
spectrometric based strategies, combining the identification and
quantification of proteins have been used to perform a global
quantitative proteomic analysis of a Drosophila model of
Parkinson disease [18]. These approaches led to the identification
of specific proteins and altered functional protein families and
protein networks.
Efficient analysis of large amounts of raw data for peptide and
protein identification and quantification in complex protein
mixtures is a challenge in mass spectrometry-based proteomic
approaches. Two strategies have been developed to overcome
difficulties. In one approach, labels are incorporated within the
peptides and proteins; in the other no label is used [19]. The use of
labels, based on the principle of stable isotope dilution theory,
introduces mass tags that can be incorporated metabolically,
chemically or enzymatically. Chemical label strategies include
isotope coded affinity tags (ICAT) [20], or isobaric tags such as
iTRAQ [21], which involve the use of a derivatization reagent for
chemical modification of proteins in a site-specific manner. These
labels are chemically identical within the peptides from two (or
more) samples and will thus present identical chromatographic
properties and ionization efficiency, allowing different samples to
be analyzed and quantified simultaneously by mass spectrometry.
In label-free methods, quantification is obtained by directly
correlating the MS signal intensity and the relative or absolute
protein quantity. This can be achieved either by a spectral
counting approach, using MS/MS acquired data and counting the
number of fragment spectra leading to protein identification
[22,23], or by comparative analysis of precursor ion intensities
[24,25]. Among the label-free approaches, the data-independent
LC-MS
E method provides accurate mass information on both the
precursor and their associated fragment ions, in low and elevated
energy mode, respectively, whilst concurrently recording the
intensity of both ion types. This label-free LC-MS method allows
the identification of proteolytic peptides over a relatively high
dynamic range and protein quantification via normalization of the
LC-MS datasets through comparison of the peptide intensities
across multiple data sets [25,26]. An addition to the scanning
method includes the molar amount determination for each
identified protein, using the intensity peptide ratio from a given
protein to that of a reference [27].
To identify modulators of the prion Sup35p conversion, we
have developed a functional proteomic study. First, we have
fractionated Saccharomyces cerevisiae extracts from [PSI
+] and [psi
2]
cells using a sucrose gradient. The effect of each fraction was tested
on Sup35p assembly in vitro. Two fractions exhibiting significant
differences on Sup35p polymerization were selected as they might
contain protein factors involved in [PSI
+] propagation. In order to
determine qualitative and quantitative changes in the protein
composition of the different fractions, we performed a multiplex
comparison between the fractions using a proteomic analysis based
on a gel-free and label-free LC-MS approach. We obtained
interesting protein profiles for each fraction and were able to
observe not only qualitative but also quantitative differences
between proteins of each of these fractions. This first functional
proteomic study using a data-independent LC-MS scanning
method reveals interesting changes in proteins belonging to the
protein folding and/or protein degradation pathways and
emphasizes the role of some functional protein families in prion
propagation.
Materials and Methods
Expression and purification of Sup35p
Sup35p was overexpressed in E. coli strain BL21-CodonPlus, in
26YT media complemented with chloramphenicol (34 mg/ml)
and carbenicillin (100 mg/ml), at 30uC. At OD600=0.5–0.7,
protein expression was induced with 1 mM IPTG. The bacterial
pellets were resuspended in 20 mM Tris–HCl, pH 8.0, 1 M NaCl,
20 mM imidazole, 5 mM b-mercaptoethanol, 5% glycerol,
supplemented with EDTA-free protease inhibitor cocktail tablets
(Complete, Roche Diagnostics Gmbh, Mannheim, Germany).
After disruption of the cells by sonication, Sup35p was purified
and stored in 50 mM Tris-HCl, pH 8.0, 1 M NaCl, 5 mM ß-
mercaptoethanol, 5% glycerol, 10 mM MgCl2 and 2 mM EGTA
at 280uC as described [11]. Sup35p was dialyzed for 1h30 against
assembly buffer (50 mM Tris-HCl, pH 8.0, 200 mM NaCl, 5%
glycerol, 5 mM ß-mercaptoethanol, 5 mM GTP, 10 mM MgCl2).
Cytosolic Yeast extract fractionation
74D-694 [MAT alpha, ade1-14(UGA), trp1-289(UGA), his3 D -
200, ura3-52, leu2-3, 112] [PSI
+, PIN
+], and 74D-694 [MAT alpha,
ade1-14(UGA), trp1-289(UGA), his3 D - 200, ura3-52, leu2-3, 112]
[psi
2, PIN
+] yeast strains were grown in YPD medium supple-
mented with adenine 0.75 mM to an optical density at 600 nm of
2–4. The cells were spun (2,000 RPM at 4uC for 5 minutes,
JLA8.1000 rotor, Beckman Instruments, Inc., California) and
rapidly washed twice with water. A volume of glass beads (0.45–
0.5 mm, B. Braun biotech international, GmbH, Germany) equal
to that of the final pellets (2 ml) was added to the pellets and 2 ml
of the protein extraction buffer (25 mM Tris HCl, pH 7.5, 50 mM
KCl, 10 mM MgCl2, 1 mM EDTA supplemented with Complete
protease inhibitors, Roche Diagnostics, GmbH, Germany, 1 caplet
for 25 ml) were added. The cells were then harvested by vigorous
shaking (8 shaking cycles of 30 seconds each spaced by 30 second
pauses on ice). The mixture was then spun (3,000 RPM at 4uC for
5 min) and the supernatant (2 ml) recovered and loaded within
20 min on premade 60-20% sucrose gradients. The tubes were
immediately inserted in a Beckman SW41TI rotor and spun at
77,000 g for 4.5 h at 4uC using an Optima L90K Beckman
ultracentrifuge (Beckman Instruments, Inc., Brea, CA). The rotor
was allowed to stop without a break. 1 ml fractions were collected
from the bottom to the top of each tube and labeled fraction 1
(bottom of the tube, 60% sucrose) to 8 (top of the tube, 0%
sucrose). The fractions were aliquoted, flash frozen and stored at
280uC.
The sucrose gradients were prepared by loading 1.4 ml layers of
sucrose 60, 50, 40, 30 and 20% in 14689 mm polyallomer
centrifuge tubes (Beckman Instruments, Inc.). The tubes were then
frozen and thawed prior to use.
Assembly of Sup35p into protein fibrils
Sup35p assembly reactions were monitored as described [11]
using thioflavin T binding [28]. When assembly was performed in
the presence of fractionated cytosolic yeast extract, the different
fractions were dialyzed against assembly buffer prior to the
addition of soluble Sup35p (7 mM). The final fractionated cell
extract concentration in the assembly reaction was 0.48 mg/ml.
Proteomic Analysis of [PSI
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The protein fractions were dialyzed against 50 mM ammonium
bicarbonate (pH 8.5) for 2 h and spun 15 min at 14,500 RPM and
4uC. The pellets were discarded and the protein concentrations in
the supernatants determined using the Bradford assay [29]. High
purity bovine serum albumin (BSA, Sigma-Adrich, St. Louis, MO)
was added as an internal standard. This internal standard allows
monitoring experimental variation during sample digestion and
LC-MS measurements. The protein concentrations were adjusted
to a final concentration of 200 fmoles/ml of BSA and 0.4 mg/ml
of the sucrose gradient fractions in presence of 0.1% RapiGest
(Waters corporation, Milford, MA) [30]. The proteins were then
reduced in the presence of 5 mM dithiothreitol at 56uC for 30 min
and alkylated in 15 mM iodoacetamide in the dark at room
temperature for 30 min. Protein digestion was performed at 37uC,
overnight, using trypsin (Promega, Madison, WI) at a protein to
protease ratio of 50:1 (w:w). Trypsin digestion and RapiGest
treatment were stopped by the addition of an equal volume of
500 mM HCl followed by incubation at 37uC for 45 min. The
tryptic peptide samples (0.2 mg/ml of total yeast protein and
50 fmoles/ml of BSA) were spun for 10 min at 14,500 RPM. The
supernatant was rapidly frozen and stored at 280uC until further
analysis.
Liquid chromatography - mass spectrometry
Reversed-phase separation of the tryptic peptides was per-
formed using a nanoAcquity system (Waters Corporation, Milford,
MA) equipped with a 180 mm620 mm Symmetry C18 5 mm trap
column and a 75 mm6200 mm BEH C18 1.7 mm analytical
column. Solvent A was water with 0.1% formic acid. Solvent B
was acetonitrile with 0.1% formic acid. Peptides were eluted from
the column using the following gradient at a flow rate of 300 nl/
min: 3 to 40% solvent B in 90 min, 40 to 90% solvent B in 1 min,
90% B for 4 min and re-equilibration with 3% solvent B for
20 min (Figure S2). The lock mass solution, comprising [Glu
1]-
Fibrinopeptide B in 0.1% formic acid in water/acetonitrile (75:25,
v/v), was delivered by the auxiliary pump of the nanoAcquity
system to the reference sprayer of the NanoLockSpray source at a
concentration of 200 fmoles/ml. The samples were mixed with an
equal volume of a solution containing 25 fmoles/ml of Phosphor-
ylase B predigested with trypsin (Waters Corporation, Manchester,
UK). Pre-digested Phosphorylase B was added as a technical LC-
MS variation internal standard. Finally, 2.5 ml of the digested
samples were loaded on the column with 3% of solvent B,
corresponding to 250 ng of total protein digest, 62.5 fmoles BSA
and 31.25 fmoles Phosphorylase B. Triplicate measurements were
performed for each sample. Mass spectrometric analysis of the
tryptic peptides was performed with a Q-TOF Premier mass
spectrometer (Waters Corporation, Manchester, UK). The
instrument was operated in data independent, alternate scanning
(LC-MS
E) acquisition mode. The acquisition time for each mode
was 1 s. At low energy, the collision energy was kept constant at
4 eV, whilst at elevated energy the collision energy was ramped
from 15 to 35 eV during the acquisition. The interscan delay time
was 0.1 s. The cone voltage was set at 24 V to prevent in-source
fragmentation and the m/z acquisition range was from 50 to 1990
for both acquisition modes.
Biological replicates, corresponding to independent cell cultures,
extracts preparation and fractionation, denoted fractions 4B
[psi
2], [PSI
+] and 6B [PSI
+], were analyzed as described above.
Data processing: Protein identification and quantification
The nanoscale LC-MS data were processed and searched using
ProteinLynx GlobalSERVER (PLGS) v2.3 (Waters Corporation).
The qualitative part of the software utilizes the physicochemical
properties of polypeptides and statistical models [31]. Protein
identification data are presented in Table S1 (and Table S5A for
independent biological replicates). Quantitative label-free LC-MS
analyses are described and justified in detail in the results section
‘Qualitative and quantitative multiplexed proteomic analysis of
cytosolic sucrose fractions from [PSI
+] and [psi
2] by LC-MS’. The
detailed identification and quantification procedure is presented in
File S1.
Isoform processing
The data were processed manually for protein paralogs. For
homologous proteins, the observed signal intensity arising from
sequences common to different polypeptides can result in
redundant identifications. This is advantageous from a qualitative
perspective since the intensity of the redundant peptides is
cumulative. However, this leads to difficulties in quantitatively
assessing individual protein paralogs. When isoform specific
peptide sequences were detected, a quantification of protein
isoforms was carried out. If not, the different isoforms were
reported as a single protein homology group and an absolute
amount assigned to the group as a whole. In the case of the
chaperones Ssa1-4 and Sse1-2, a novel filtering method (Table S6),
using an extension to the earlier presented absolute quantification
scheme, was applied. Namely, the average intensity was calculated
for every isoform proteotypic peptide. The proteotypic peptide
intensities were subsequently used to segment the total intensity of
the common peptide belonging to each parent protein. Next, the
peptides were re-ordered based on their segmented intensities for
the common sequences and non-segmented intensities for the
proteotypic peptides and the molar amounts calculated. When a
given peptide was not identified by the software, its intensity
information was retrieved manually using its accurate mass and
retention time.
Biological functions of the identified proteins were completed
following Gene ontology annotation at http://db.yeastgenome.
org/cgi-bin/GO/goSlimMapper.pl.
Results
[PSI
+] and [psi
2] cytosolic fractions promote the assembly
of Sup35 into fibrils
To identify regulators of Sup35p assembly, total cytosolic
extracts from [PSI
+] and [psi
2] yeast strains were prepared and
fractionated on 20–60% sucrose gradients. The effects of these
fractions after dialysis on Sup35p were monitored using thioflavin
T binding (Figure 1 and Figure S1 for independent biological
replicates).
Most fractions exhibited limited or no effect on Sup35p
assembly, as for example fraction 6 from [PSI
+]o r[ psi
2] (20–
30% sucrose, containing protein complexes of 1.62 to 7.6 MDa).
Fractions 4 however, (40% sucrose, containing protein complexes
of 35.6 to 167 MDa) from both yeast strains affected the lag phase
preceding the assembly of Sup35p into fibrils, diminishing it from
,15 hours in the control reaction to 1–4 hours. Moreover,
thioflavin T fluorescence intensity at steady state increased very
significantly, although to different extents, in the presence of
proteins present in fractions 4 from both yeast extracts suggesting
an increase in the amount of assembled Sup35p. Interestingly, the
extent of thioflavin T fluorescence increase was higher in the
presence of fraction 4 from [PSI
+] than from [psi
2] cells while the
nucleation phase was shorter in the presence of fraction 4 from
[psi
2] than from [PSI
+] cells. This effect is not due to the extracts
Proteomic Analysis of [PSI
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incubated under the same conditions without exogenous Sup35p.
We conclude from these observations that the cytosol of [PSI
+]
and [psi
2] yeast strains differ by the factors that modulate the
assembly of Sup35p into protein fibrils. To unveil these
differences, the protein content of fractions 4 from [PSI
+] and
[psi
2] yeast strains were compared. As fractions 6 from both yeast
strains are devoid of an assembly stimulatory activity, these protein
fractions can be used as a control. We therefore also compared the
protein content of fractions 4 and 6.
Qualitative and quantitative multiplex proteomic analysis
of cytosolic fractions from [PSI
+] and [psi
2] yeasts by LC-
MS
A comprehensive multiplex comparison of the protein compo-
sition of fractions 4 from [PSI
+] and [psi
2] cell extracts and of
fractions 4 and 6 from [PSI
+] cell extract was performed in order
to identify modulators of Sup35p assembly. This proteomic
comparison was done after adjusting the protein concentrations
to the same value following the LC-MS approach described in
Figure 2 and the Materials and Methods section. The samples
were spiked with BSA prior to trypsin digestion and with
Phosphorylase B prior to LC-MS measurement. These two
internal standards were used to normalize the data and calculate
variations between samples. Tryptic peptides eluted from the LC
system were analyzed on-line in a multiplexed fashion as described
in the Materials and Methods section. The low energy acquisition
trace in Figure S2 shows a continuous measurement of the m/z
values of all the eluted and ionized tryptic peptide ions at a given
time point of the separation process. The high energy acquisition
trace collected in parallel comprises the fragmentation products of
those peptides. An inventory of peptide precursors along with their
time-resolved fragment ions was generated. The use of a novel
database search strategy designed for data independent acquisi-
tions, together with the accurate mass measurements of both
precursors and fragment ions, the high reproducibility of the
chromatographic separation, the time alignment of the m/z values
of both the precursors and the associated fragmentation ions
obtained at high energy, allows identification of proteins with high
confidence [31,32]. The analysis of the deconvoluted low energy
m/z data of all the precursor peptides over an entire chromato-
graphic peak allows quantification of peptides and proteins in large
scale proteomic studies.
Such analyses rely on the hypothesis that most of the proteins
within the samples that are compared are similar. This is the case
when proteins present within a given fraction from [psi
2] and
[PSI
+] cell extracts (e.g. fractions 4) are compared. However,
significant differences in the protein composition of fractions are
expected when different fractions from one sucrose gradient (e.g.
fraction 4 and fraction 6 from [PSI
+]) are compared. In the latter
case, the LC-MS approach requires a normalization procedure
between samples using an internal standard. This was addressed,
in this study, by expressing the amounts of a protein of interest as a
fraction of the total amount of proteins per individual fraction and
experiment. This multiplexed approach allows not only the
identification of a large number of proteins over a high dynamic
range, but also the quantitative comparison of several protein sets
associated to different biological activities, even when the protein
composition is vastly different.
In the qualitative analysis, the protein composition of the three
fractions were compared (fractions 4 from [psi
2] and [PSI
+] and
fraction 6 from [PSI
+]) using a single-dimension reversed phase
gradient separation (Figure S2) and the detection and identifica-
tion process previously reported [32]. The list of the identified
yeast proteins is presented in Table S2. The number of proteins
identified in at least two out of three technical replicates for
fraction 4 [psi
2], 4 [PSI
+] and 6 [PSI
+] is 124, 134 and 231,
respectively. The reproducibility of protein identification is about
80%. The biological processes where each identified protein is
involved were determined using gene ontology annotation and are
given. Whereas, the highest number of identified proteins are
involved in metabolic and protein translation processes, a third
category of proteins of interest is involved in protein folding and
modification (Figure 3 A, B and C). The changes for proteins
belonging to the latter category within the three fractions we
compared are represented (Figure 3 D and E).
In the multiplex quantitative analysis, proteins were quantified
using their composite MS signal response as developed by Silva et
al [32,33]. The search algorithm and the normalization procedure
are described in the Materials and Methods section and File S1.
We determined the individual concentration of the 340 yeast
proteins that were identified in at least two replicates (Table S2).
The protein concentrations ranged from 0.03 ng/ml to 11.11 ng/
ml. As an example, the quantitative analysis of actin and
chaperones Ssb1/2 was validated by Western blot analysis (Figure
S3). A 40% change in protein concentration was considered as
significant.
Our strategy allowed identifying protein fractions composition
and quantitative changes in [PSI
+] and [psi
2] fractions composi-
tion.
Comparison of [PSI
+] and [psi
2] protein fractions that
promote Sup35p assembly
We first compared the protein composition of fractions 4 from
[PSI
+] and [psi
2] cells. Both fractions promote Sup35p assembly
but to a different extent (Figure 1). The proteins we identified and
quantified in these fractions are listed in Table S2 and compared
in Table S3 (and Table S5B and S5C for independent biological
replicates) and the biological processes distribution in which they
Figure 1. Assembly of full-length Sup35p into protein fibrils in
the presence of cytosolic fractions from [PSI
+] and [psi
2] cells.
Soluble Sup35p (7 mM) was incubated at 10uC in assembly buffer with
no addition (solid circles) or containing 0.48 mg/ml of fraction 4 from
[PSI
+] (solid squares), or [psi
2] (solid triangles) cells. The time course of
Sup35p assembly in the presence of cytosolic fraction 6 from [PSI
+]o r
[psi
2] cells superimposes to that with no addition. Statistic analysis of
the differences in fluorescence intensity between fractions was made
using a Student T-test calculation. The P values were 0.03, 0.017 and 0.6
for fraction 4 [PSI
+] versus fraction 6 [PSI
+], fraction 4 [psi
2] versus
fraction 6 [PSI
+]a n df r a c t i o n4[ psi
2]v e r s u sf r a c t i o n4[ PSI
+]
comparisons, respectively.
doi:10.1371/journal.pone.0023659.g001
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independent biological replicates. Over 90% of the proteins
identified in fractions 4 from [psi
2] and [PSI
+] are involved in
protein translation (94 and 102 proteins, respectively), in protein
fate, including protein folding, degradation and modification (10
and 11 proteins, respectively) and in metabolic processes (10 and
12 proteins, respectively). A number of proteins such as elongation
factor Tef1, ribosomal proteins, Hsp70 chaperones Ssb1/2 and
guanine nucleotide binding protein Asc1 were abundant (from 0.5
to 5 ng/ml) in both fractions 4. Additional proteins, such as
aspartate transcarbamylase Ura2 and the elongation factors Eft1
and Yef3 are abundant in fraction 4 from [PSI
+].
Over seventy ribosomal proteins constituting the 40S and the
60S ribosome moieties: subunits Rps 0 to 31 and subunits Rpl1
to 43 together with Rpp0 were identified in fractions 4 from
[psi
2]a n d[ PSI
+] cells and their measured concentrations were
similar (0.6 to 1 ng/ml). As a functional ribosome, composed of
one 40S and one 60S, has an approximate mass of 4.2 MDa and
given that proteins with molecu l a rm a s s e so f3 5t o1 6 7M D aa r e
expected in fraction 4 of our sucrose gradients (40% sucrose),
the ribosomes we detected most probably form polysomes
composed of several ribosomes interacting with mRNA
molecules and associated proteins or protein complexes.
Amongst associated complexes, weh a v ei d e n t i f i e dt h eR i b o -
some-associated complex (RAC) involved in the biogenesis of
newly synthesized polypeptides. This complex corresponds to a
Ribosome-anchored chaperone network composed of the Hsp40
Zuotin (Zuo1) and the Hsp70 Ssz1 interacting with Ssb1/2 [34]
and has been reported as a potent antagonist of Sup35p
prionogenesis [35]. We also identified yeast Rpl31 that acts as a
contact point between RAC and the large ribosomal subunit at
the polypeptide tunnel exit [34]. The concentrations of RAC
complex subunits (0.47, 0.78 and 2 ng/ml+/20.14 ng/mlf o r
Zuo1, Ssz1 and Ssb1/2, respectively) suggest that a significant
fraction of Ssb1/2 remains available for other protein-protein
interactions. We also identified Egd1/Egd2 that form the NAC
complex (nascent polypeptide-associated complex) which inter-
acts with nascent polypeptide chains, the RAC complex and
proteins from the Hsp70 family. A limited number of proteins
involved in protein folding and degradation processes were
identified in fractions 4 from [psi
2]a n d[ PSI
+]c e l l s .S s b
chaperone proteins (i.e. Ssb1/2) were particularly abundant in
both fractions (about 2 ng, i.e. 2% of the total protein content).
Chaperones from the Hsp70 family (Ssa1/Ssa2/Ssa3/Ssa4,
Ssb1/Ssb2 and Ssz1) were also detected.
The differential distribution of proteins for which concentration
differs in fraction 4 from [psi
2] and [PSI
+] cells is shown in
Figure 4. Most of the 23 proteins for which expression levels are
increased in fraction 4 from [psi
2] cells are involved in different
steps of the protein translation process (Dbp1, Egd2, Nop7, Sro9,
Cic1, Gcd11, Tif4631, Pab1 and Sup45, and Rps15), in different
metabolic processes (Pda2, Imd1/2/3/4, Lat1), in protein folding
(Ssa3, Ssa4) and in other functional processes (Fks1, Kem1,
Scp160, Vps1, Yra1, Pma1/2). The 31 proteins for which
expression levels are increased in fraction 4 from [PSI
+] cover
five classes of biological processes: protein translation initiation
(Tif5, Tif32, Nip1, Prt1, Rpg1) and elongation (Hef3, Eif2A, Eft1,
Yef3), ribosome biogenesis necessary for protein translation
(Rpl42A, Rps29A, Rps30A, Rps31, Rps25A, Rps8A, Mrt4,
Arx1), metabolic process (Adh1/2, Ilv5/5G, Tdh1/2/3, Pfk1,
Pfk2, Fas1, Fas2), transport processes (New1, Nop3), protein
folding (Sse1) and protein modifications (Nat1, Ubi3). Similar
observations were made with independent biological replicates
(Figure S5). Changes in the concentration of the molecular
chaperones we identified within fractions 4 from [psi
2] and [PSI
+]
cells appear limited, as shown in Figure 5.
Figure 2. Strategy for qualitative and quantitative proteomic analysis of proteins involved in regulation of Sup35p assembly. This
scheme summarizes the different steps of the experimental strategy detailed in materials and methods Section, from yeast protein extracts to the
qualitative and quantitative LC-MS analysis.
doi:10.1371/journal.pone.0023659.g002
Proteomic Analysis of [PSI
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+] cells that
affect or not Sup35p assembly
To further identify modulators of Sup35p assembly, we
compared the protein content of fractions from [PSI
+] cells that
affect or not Sup35p assembly, fractions 4 and 6, respectively
(Table S4, and S5D for independent biological replicates). The
number of proteins identified in fraction 6 from [PSI
+] was much
higher than that in fraction 4 in independent biological replicates
(Figure 3E and Figure S4E). Over 80% of the proteins identified in
fraction 6 are involved in processes ranging from metabolic (101
proteins) to transport (14 proteins), cell growth (10 proteins) and
protein translation (50 proteins). Proteins involved in protein
folding (18 proteins), degradation (17 proteins) and modifications
(4 proteins) processes represent 16% of the proteins identified
(Figure 3). Comparison of the protein contents of fractions 6 and 4
from [PSI
+] cells shows that they differ significantly. While proteins
involved in metabolic processes (e.g. biosynthesis of amino acids,
lipids, purines, cofactors, RNAs and nucleosides, carbohydrate
metabolism and glycolysis) represent 9% of the proteins in fraction
4, they represent 44% of the proteins in fraction 6 and about 60%
of total protein weight. These proteins are either unique to fraction
6 or their concentration is significantly higher in this fraction.
About 20% of the proteins within fraction 6 (25% of total protein
weight), are involved in protein translation processes (20 tRNA
amino acid synthetases or acylases, 19 proteins involved in
regulation of initiation and elongation of the protein translation
process as well as 14 ribosomal proteins, 8 of which belonging to
the 40S ribosomal subunit). The functional partner of Sup35p, the
eukaryotic peptide chain release factor eRF1, or Sup45p, was
detected only in fraction 4.
Except Rpl40A (a fusion protein of Ubiquitin and ribosomal
protein L40), identified only in fraction 6, ribosomal proteins
represent 5% (0.8% of total protein mass) of the proteins in
fraction 6 while they represent 55% of the proteins (75% of total
protein mass) in fraction 4. In contrast, tRNA amino acid
synthetases are exclusively identified in fraction 6. The most
interesting differences were observed for proteins involved in
protein fate, including protein folding, protein degradation and
protein modifications. Only 11 proteins are involved within these
biological processes in fraction 4, while 39 proteins lie within this
category in fraction 6 (Figure 3 and Table 1). Seventeen out of the
39 proteins we identified are constituents of the Ubiquitin
Proteasomal System (6 regulatory subunits from the 19S Protea-
some complex with 5 Rpn and 1 Rpt subunits, and 10 subunits
from the 20S Proteasome Core with 7 Pre, 2 Pup subunits and
Scl1) as well as Ubiquitin. None of these proteins are present in
fraction 4 from [PSI
+]o r[ psi
2] cells. Finally, their concentrations
ranged from 0.04 to 0.1 ng/ml.
Figure 3. Qualitative comparison of proteins identified in the
selected sucrose gradient fractions. (A), (B) and (C) represent the
distribution of the major biological process of each of the 124, 134 and
231 proteins identified in fractions 4 from [psi
2] cells, fraction 4 from
[PSI
+] cells and fraction 6 from [PSI
+] cells. (D) and (E) illustrate the
qualitative comparison between fractions 4 [psi
2] versus fraction 4
[PSI
+] and fraction 4 [PSI
+] versus fraction 6 [PSI
+], respectively.
doi:10.1371/journal.pone.0023659.g003
Figure 4. Differential distribution of proteins for which
concentrations differs between the selected fractions. (A) and
(D) correspond to the comparison of proteins identified in fraction 4
[psi
2] versus fraction 4 [PSI
+] and in fraction 4 [PSI
+] versus fraction 6
[PSI
+] respectively. (B) and (C) represent the distribution of the major
biological processes attributed to proteins increased in fraction 4 [psi
2]
and fraction 4 [PSI
+] respectively. 23 and 31 unique or significantly
increased proteins are present within fractions 4 [psi
2] and [PSI
+],
respectively. (E) and (F) represent the distribution of the major
biological processes attributed to proteins increased in fraction 4
[PSI
+] and fraction 6 [PSI
+] respectively. 109 and 211 unique or
significantly increased proteins are present within fractions 4 and 6
from [PSI
+] cells, respectively.
doi:10.1371/journal.pone.0023659.g004
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and Sse1 identified in fraction 4, the chaperones and co-
chaperones Sse2, Ssc1, Ydj1, Hsp60, Hsc82, Hsp104, Hsp10
and Cpr1, Cpr6, Sti1 and Sgt2 which are involved in protein
folding, were only detected in fraction 6 (Figure 5). Some of these
identified protein chaperones were validated by Western blotting
(Figure S3). While Ssb1/2 concentrations were similar, Ssa2
concentration was one order of magnitude higher in fraction 6
than in fractions 4. Zuo1 and Ssz1 were not detected within
fraction 6. This suggests that the ribosome-associated RAC
complex is absent from fraction 6.
Discussion
The cytosolic protein fractionation coupled to the functional
studies and qualitative and quantitative multiplexed label-free
proteomic analysis we present here was intended to identify
proteins that modulate Sup35p assembly and [PSI
+] emergence
and propagation in yeast cells.
Comparison of the protein content of cytosolic fractions that
promote Sup35p assembly to different extents (fractions 4 from
[psi
2] and [PSI
+] cells) reveals discrete differences. These fractions
are rich in proteins involved in protein translation and folding and
in metabolic processes. Proteins found only in fraction 4 from
[PSI
+] cells can be related to changes in biological processes within
[PSI
+] yeast cells due to the prion phenotype. The major changes
we observed affect metabolic pathways and cellular proteostasis
that may lead to changes in protein synthesis, folding and
degradation.
Comparison of the protein content of cytosolic fractions that
have no effect on Sup35p assembly and that promote Sup35p
assembly (fractions 6 and 4 from [PSI
+] cells) reveals significant
changes. These differences concern proteins involved in protein
translation, folding and degradation. They also concern protein
involved in oxido-reduction and metabolic processes. We
previously documented the functional interplay between Hsp104,
70 and 40 family members [11]. The effects of cytosolic fractions
on Sup35p assembly we report here underline the importance of
molecular chaperone interplay. Our analysis also provides the first
inventory list of chaperones possibly involved in [PSI
+] propaga-
tion and/or changes in cellular proteostasis due to the [PSI
+]
element.
Proteins involved in polypeptide folding
Molecular chaperones facilitate the folding of newly synthesized
proteins, are involved in protein quality control, assist the assembly
of several macromolecular complexes and limit protein aggrega-
tion [36]. Several Hsp70 family members (Ssa1, Ssa2, Ssa3, Ssa4,
Ssb1/2 and Ssz1) and one co-chaperone Hsp40 (Zuo1) were
identified in [PSI
+] and [psi
2] cytosolic fractions (fraction 4) that
favor Sup35p assembly. Ssa1 and Ssa2 are constitutively expressed
chaperones that bind to denatured proteins and prevent
aggregation, while Ssa3 and Ssa4 are heat-inducible. Ssb1
interacts with two co-chaperones to form the ribosome-associated
Ssb1:Zuo1:Ssz1 complex [37], recently identified as a potent
inhibitor of Sup35p assembly and antagonist of prionogenesis [35].
Fractions 4 from [PSI
+] and from [psi
2] cells promote Sup35p
assembly. This indicates that protein modulators tune the
inhibitory activity of the RAC complex. Indeed, our observations
suggest either that the RAC complex does not act post-
translationally or is unavailable because of its interaction with
polysomes within these fractions. This finding illustrates the
importance of performing a global analysis such as that presented
here.
The proteins involved in protein folding we identified in fraction
6 from [PSI
+] cells were either unique to this fraction or present at
Figure 5. Quantification of cytosolic proteins involved in protein folding. The protein amounts in fraction 4 [psi
2] (blue), fraction 4 [PSI
+]
(red) and fraction 6 [PSI
+] (green) were determined as explained in Materals and Methods section. The protein amounts are femtomoles of proteins
measured in one microliter of the fractions. The sum of Ssa, Ssb and Sse isoforms is shown in the inset. Error bars correspond to technical variation.
doi:10.1371/journal.pone.0023659.g005
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with the exception of Zuo1 and Ssz1, specific to fractions 4, and
Ssb1/2 at similar concentrations in both fractions. The nineteen
proteins we identified, amongst which one small Heat shock
protein from the GroES chaperonin family (Hsp10), one Hsp40
homologue (Ydj1), one Hsp60, Hsp70 homologues (Ssa1, Ssa2,
Ssa3, Ssa4, Ssb1/2, Ssc1, Sse1, Sse2), Hsp90 homologues (Hsp82/
Hsc82) and one Hsp100 homologue (Hsp104), represent 11 ng
(i.e. 8% of the total protein weight).
Proteins involved in polypeptide degradation
The 26S proteasome is a 2.5 MDa multi-subunit intracellular
protease [38] that eliminates proteins, in particular misfolded proteins,
targeted for degradation. The 26S proteasome consists of the 20S
proteolytic core complex and two 19S regulatory subunits [39].
We have identified ten subunits of the 20S proteasome: six
alpha subunits (Pre5, 6, 9, 10, Pup2 and Scl1) and four beta
subunits (Pre2, 3, 7 and Pup3), as well as six subunits of the 19S
proteasome: five subunits of the lid (Rpn5, 6, 7, 8, 11) and one
subunit of the base (Rpt6), in fraction 6 but not in fraction 4 from
[PSI
+] cell extracts.
Proteins involved in polypeptide modifications
Ubiquitin was identified in fractions 4 and 6 from [PSI
+] cells.
Ubiquitin is covalently attached to lysine residues either as a
monomer or as a polymer. Unlike mono-ubiquitination, poly-
ubiquitination is believed to target polypeptides to the proteasome.
The overall concentration of ubiquitin in fractions 4 and 6 was
similar (0.38 and 0.60 ng/ml, respectively). However, while Ubi3,
a poly-protein with one ubiquitin fused to the ribosomal protein
S37 was identified in fraction 4, Ubi1 a poly-protein with one
ubiquitin fused to the ribosomal protein L40 and Ubi4 a poly-
protein containing five repeats of ubiquitin were found in fraction
6.
Table 1. Multiplexed quantitative data of proteins involved in protein degradation and modification.
Fraction 4 [psi
2] Fraction 4 [PSI
+] Fraction 6 [PSI
+]
Accession
n6
Accession
name Protein name
Gene
name
n
rep
n
pep ng/ml RSD
n
rep
n
pep ng/ml RSD
n
rep
n
pep ng/ml RSD
P38779 CIC1_YEAST Proteasome-interacting protein CIC1 CIC1 2 4.50 0.04 0.35 00
P21242 PSA3_YEAST Proteasome component C1 PRE10 0 0 2 6.00 0.05 0.01
P30656 PSB5_YEAST Proteasome component PRE2 PRE2 0 0 3 4.67 0.05 0.39
P38624 PSB6_YEAST Proteasome component PRE3 PRE3 0 0 3 5.00 0.07 0.62
P40302 PSA1_YEAST Proteasome component PRE5 PRE5 0 0 3 9.00 0.09 0.07
P40303 PSA7_YEAST Proteasome component PRE6 PRE6 0 0 2 6.00 0.13 0.01
P23724 PSB1_YEAST Proteasome component C5 PRE7 0 0 3 3.00 0.06 0.27
P23638 PSA4_YEAST Proteasome component Y13 PRE9 0 0 3 4.33 0.06 0.27
P32379 PSA5_YEAST Proteasome component PUP2 PUP2 0 0 3 7.00 0.11 0.14
P25451 PSB3_YEAST Proteasome component PUP3 PUP3 0 0 3 2.00 0.04 0.01
P43588 RPN11_YEAST 26S proteasome regulatory
subunit RPN11
RPN11 0 0 2 3.50 0.06 0.64
Q12250 RPN5_YEAST 26S proteasome regulatory
subunit RPN5
RPN5 0 0 2 6.50 0.07 0.40
Q12377 RPN6_YEAST 26S proteasome regulatory
subunit RPN6
RPN6 0 0 2 6.50 0.09 0.31
Q06103 RPN7_YEAST 26S proteasome regulatory
subunit RPN7
RPN7 0 0 2 4.00 0.03 0.01
Q08723 RPN8_YEAST 26S proteasome regulatory
subunit RPN8
RPN8 0 0 2 5.00 0.06 0.13
Q01939 PRS8_YEAST 26S protease regulatory subunit
8 homolog
RPT6 0 0 2 7.50 0.06 0.01
P21243 PSA6_YEAST Proteasome component C7-alpha SCL1 0 0 3 6.67 0.06 0.09
P12945 NAT1_YEAST N-terminal acetyltransferase A
complex subunit NAT1
NAT1 0 2 2.50 0.07 0.01 0
P41940 MPG1_YEAST Mannose-1-phosphate
guanosyltransferase
MPG1 3 7.33 0.15 0.31 3 10.00 0.21 0.27 3 14.000.65 0.09
P61864 UBIQ_YEAST Ubiquitin UBI1 0 0 3 3.67 0.10 0.10
P05759 RS37_YEAST 40S ribosomal protein S31 UBI3 1 3 3.67 0.38 0.03 0
A7A0L9 A7A0L9_YEAS7 Poly-ubiquitin UBI4 0 0 3 3.67 0.50 0.11
P43616 CPGL_YEAST Glutamate carboxypeptidase-like
protein
YFR044C 0 0 2 4.50 0.07 0.11
Accession number, accession name, protein name and gene name are indicated for each identified protein. For each analyzed fraction, the number of replicates in
which the protein was identified (n rep) is indicated, together with the number of identified peptides (n pep), the average amount of protein identified in one microliter
(ng/ml), and the relative standard deviation (RSD).
doi:10.1371/journal.pone.0023659.t001
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(Nat1), critical for the normal function of proteins that need being
acetylated, was only found in fraction 4.
Proteins that affect cellular proteostasis
Proteins involved in protein translation, ribosomal proteins,
and/or proteins regulating initiation, elongation or termination of
protein translation, differed considerably both in fractions 4 from
[psi
2] and [PSI
+] cells and in fractions 4 and 6. Fractions 4 from
[psi
2] and [PSI
+] were enriched in polysomes. Interestingly, the
ribosome possesses an intrinsic protein folding activity [40–42] of
which down-regulation destabilizes prion traits [43].
Regulatory factors involved in initiation, elongation and/or
termination of protein translation, were overrepresented in
fractions 4 from [PSI
+] as compared to that from [psi
2] cells.
Sup35p partner, Sup45p (i.e. eRF1) was detected in fractions 4
from [psi
2] and [PSI
+] cells but not in fractions 6. Several
translation initiation factors, such as Tif32, Prt1, Nip1, Tif34 and
Tif35 that form the core complex of the translation initiation
factor 3 complex eIF-3 were identified in fraction 4 from [PSI
+]
cells. Finally, the poly(A) binding protein- Pab1 [44] was detected
in all fractions.
Proteins involved in other cellular processes
Proteins involved in metabolic processes represent 60% of total
protein mass in fractions 6 from [PSI
+] (about 82 ng of proteins).
Tdh1/Tdh2/Tdh3 (Glyceraldehyde-3-phosphate dehydrogenase),
Pyk1 (pyruvate kinase) and Pdc (pyruvate decarboxylase) represent
each about 5% of the total protein content.
Proteins specifically involved in oxido-reduction processes such
as the thioredoxins Trx1 and Trx2 and the thioredoxin reductase
Trr1 were found in fraction 6 from [PSI
+] cells but not in fraction
6 from [psi
2] cells.
Our analysis shows that the protein content of cytosolic fractions
from [PSI
+] and [psi
2] cells that promote Sup35p assembly into
protein fibrils to different extents differs significantly. It is tempting
to relate the functional differences we observe to the protein
content of the cytosolic fractions. Molecular chaperones modulate
[PSI
+] propagation in an exquisite manner [45–50] and Sup35p
assembly into fibrils [11,35]. Given that Ssb1/2 are present at
similar concentrations in cytosolic fractions 4 and 6, the Sup35p
assembly promotion we observe for fraction 4 cannot be attributed
to these chaperones. With a similar reasoning, one reaches the
conclusion that the effect we observe must be due to a
compromized interplay between molecular chaperones that
distinguish fractions 4 from 6 either because of their absence or
lower concentrations in fraction 4. The following molecular
chaperones are good candidates: Hsp10, Ydj1, Hsp60, Ydj1,
Hsp60, Ssa1, Ssa2, Ssa3, Ssa4, Ssc1, Sse1, Sse2, Hsp82/Hsc82,
Sgt2 and Hsp104, as they either lack or are present at considerably
lower concentrations in fractions 4. The importance of a
functional interplay between chaperones in Sup35p assembly
was previously demonstrated by the analysis of the effect of protein
chaperones added individually or in combination to Sup35
assembly assays [11]. Two chaperones (Zuo1 and Ssz1) are
specific to fractions 4. These chaperones are probably present
within these fractions as a Ssb1:Zuo1:Ssz1 complex associated to
the ribosomes (RAC). They are therefore unlikely to be responsible
for the Sup35p assembly induction we observe.
The finding that fractions 4 are devoid of proteasome in
contrast with fractions 6 suggests that the Sup35p assembly
promotion we observe is not due to a proteasome-mediated
cleavage of Sup35p with generation of protein fragments with
increased nucleation ability that could serve as nuclei for
exogenous full-length Sup35p assembly. In addition, in fractions
6, the presence of Ubi4, which contributes to protein poly-
ubiquitination, together with the proteasome further suggest that
Sup35p eventual poly-ubiquitination and proteasome-mediated
degradation do not contribute to increased assembly and
nucleation ability.
Finally, our analysis unveiled a number of changes within
cellular proteostasis that are the consequence of [PSI
+]. Indeed,
while proteins involved in polypeptide translation, ribosomal
proteins, and/or proteins regulating initiation, elongation or
termination of protein translation, differed considerably in
fractions 4 from [psi
2] and [PSI
+], proteins involved in oxido-
reduction processes were present in fraction 6 from [PSI
+] cells but
not in fraction 6 from [psi
2] cells.
Our study provides the first inventory list of over 40 proteins
involved in polypeptide folding, degradation and modification that
directly or indirectly affect Sup35p assembly into protein fibrils.
We also bring evidence for changes within the expression of
proteins involved in metabolic processes and the regulation of
proteostasis upon wild-type yeast conversion into [PSI
+]. Alto-
gether, our results highlight the complexity of the cellular changes
accompanying [PSI
+] formation. This complexity can only be
further deciphered by in vitro studies where the effect of individual
and/or combinations of proteins susceptible of affecting Sup35p
assembly will be tested. Further studies destined to assess the effect
on Sup35p assembly of the molecular chaperones we identified
through this study and their interplay need being conducted. The
role of the proteasome and Sup35p degradation in the absence or
the presence of a variety of molecular chaperones on [PSI
+]
propagation and the assembly propensity of Sup35p and its
degradation products need being analyzed.
Supporting Information
Figure S1 Assembly of full-length Sup35p into protein
fibrils in the presence of cytosolic fractions from [PSI
+]
and [psi
2] cells from an independent cell extract
preparation and fractionation (biological replicates).
Soluble Sup35p (7 mM) was incubated at 10uC in assembly buffer
with no addition (solid circles) or containing 0.48 mg/ml of
fraction 4B from [PSI
+] (solid squares), or [psi
2] (solid triangles)
cells. The time course of Sup35p assembly in the presence of
cytosolic fraction 6B from [PSI
+]o r[ psi
2] cells superimposes to
that with no addition.
(TIF)
Figure S2 Reversed phase nanoLC separation obtained
for the different fractions. (A) fraction 4 from [PSI
+], (B)
fraction 4 from [psi
2] and (C) fraction 6 from [PSI
+].
(TIF)
Figure S3 Example of quantification result and valida-
tion. (A) Quantification of spiked internal standards: BSA
(ALBU_BOVIN) and Phosphorylase B (PHS2_RABIT). BSA
was used for normalization between the samples. Phosphorylase B
measures the technical replication between injections in the LC-
MS system. (B) Example of multiplexed quantification data
obtained, for two selected proteins, Actin and heat-shock proteins
ssb1/ssb2, after BSA normalization of the data. (C) Western-blot
validation of quantification using specific anti-actin or anti-Ssb1
antibodies. (D) Western-blot validation of identified chaperones
using specific anti-Ssa, anti-Hsp104 and anti-Hsp82 antibodies.
(TIF)
Figure S4 Qualitative comparison of proteins identified
in the selected sucrose gradient fractions derived from
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PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e23659an independent cell extract preparation and fraction-
ation (biological replicates). (A), (B) and (C) represent the
distribution of the major biological process of each of the 121, 156
and 215 proteins identified in fractions 4B from [psi
2] cells,
fraction 4B from [PSI
+] cells and fraction 6B from [PSI
+] cells. The
letter B refers to the replicates. (D) and (E) illustrate the qualitative
comparison between fractions 4B [psi
2] versus fraction 4B [PSI
+]
and fraction 4B [PSI
+] versus fraction 6B [PSI
+], respectively.
(TIF)
Figure S5 Differential distribution of proteins for which
concentrations differs between the selected fractions
derived from an independent cell extract preparation
and fractionation (biological replicates). (A) and (D)
correspond to the comparison of proteins identified in fraction
4B [psi
2] versus fraction 4B [PSI
+] and in fraction 4B [PSI
+] versus
fraction 6B [PSI
+] respectively. (B) and (C) represent the
distribution of the major biological processes attributed to proteins
increased in fraction 4B [psi
2] and fraction 4B [PSI
+] respectively.
33 and 68 unique or significantly increased proteins are present
within fractions 4B [psi
2] and [PSI
+], respectively. (E) and (F)
represent the distribution of the major biological processes
attributed to proteins increased in fraction 4B [PSI
+] and fraction
6B [PSI
+] respectively. 108 and 188 unique or significantly
increased proteins are present within fractions 4B and 6B from
[PSI
+] cells, respectively.
(TIF)
Table S1 Protein identification data for each replicate
sample. For each replicate sample and each identified protein, a
table of identified peptides is given.
(XLSX)
Table S2 List of proteins identified and quantified for
each replicate sample. Only non-redundant proteins identified
in at least 2 of 3 replicates were quantified. The average amount of
each protein is expressed in ng/ml. Ratios, Log ratios and two-way
unpaired T-test of the fractions to be compared are given.
(XLSX)
Table S3 List of proteins quantified in fractions 4 from
[psi
2] and [PSI
+] cells.
(XLSX)
Table S4 List of proteins quantified in fractions 4 and 6
from [PSI
+] cells.
(XLSX)
Table S5 List of proteins identified and quantified in an
independent cell extract preparation and fractionation
(biological replicates). Table S5A: Protein identification data
for each replicate sample. Table S5B: List of proteins identified
and quantified for each replicate sample. Table S5C: List of
proteins quantified in fractions 4B from [psi
2] and [PSI
+] cells.
Table S5D: List of proteins quantified in fractions 4B and 6B from
[PSI
+] cells.
(XLSX)
Table S6 Isoform filtering data obtained for the
molecular chaperones Ssa1, Ssa2, Ssa3, Ssa4, Sse1 and
Sse2.
(XLSX)
File S1 Data processing procedure for protein identifi-
cation and quantification.
(PDF)
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